Last Name


John Somberg to Antibodies, Monoclonal, Humanized

This is a "connection" page, showing publications John Somberg has written about Antibodies, Monoclonal, Humanized.

Connection Strength
  1. Nada A, Somberg J. First-in-Man (FIM) clinical trials post-TeGenero: a review of the impact of the TeGenero trial on the design, conduct, and ethics of FIM trials. Am J Ther. 2007 Nov-Dec; 14(6):594-604.
    View in: PubMed
    Score: 0.091
  2. Cobleigh M, Somberg JC. A case of herceptin cardiotoxicity. Am J Ther. 2004 Jan-Feb; 11(1):74-6.
    View in: PubMed
    Score: 0.070
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.